[TOP STORY] Have you been putting healthcare into your offshore portfolios?

Loading player...
New investors might opt for Pfizer, with its somewhat better metrics and yield, as well as its access to the mRNA technology, says Gary Booysen from Rand Swiss.
23 Jul 2021 4AM English South Africa Business News · Business

Other recent episodes

[TOP STORY] The hidden toll of debt and why early action matters

If ‘you're stuck, struggling to put food on the table or struggling to speak to your family, speak to a professional, speak to a debt counsellor, speak to a financial advisor’: Sebastien Alexanderson, Debt Advisors CEO Sebastien Alexanderson.
28 Oct 2AM 6 min

Anthropic IPO numbers surprise on the upside

Analysis of SA’s food security challenges and what the latest research reveals about access to food, plus a look at the mental toll of debt and practical ways to manage financial stress.
28 Oct 1AM 20 min

Is your Reg 28 fund pulling its weight?

Is Pick n Pay really turning around, or is Boxer masking the cracks? Merchant West Investments’s Alyssa Viljoen unpacks the results. Ninety One’s John Stopford warns of risks to equities as bonds and stocks diverge, while PSG Asset Management’s Dirk Jooste explains how understanding your Regulation 28 fund can boost…
27 Oct 1AM 21 min